Trial Profile
A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II Microsatellite-Stable or Low-Level Microsatellite-Instability Colon Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary)
- Indications Adenocarcinoma; Colon cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Sep 2016 New trial record